| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Jan 25 | AXGN AxoGen | Common Stock | Payment of exercise | Dispose F | No | No | 15.22 | 39,132 | 595.59 k | 260,868 |
| 1 Jan 25 | BCLI Brainstorm Cell Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 30,666 | 0.00 | 31,465 |
| 1 Jan 24 | AXGN AxoGen | Common Stock | Grant | Acquire A | No | No | 0 | 300,000 | 0.00 | 300,000 |
